Depression Therapeutics: SSRIs Inhibit Reuptake of Serotonin, Thereby Increasing Serotonin Activity
Depression Therapeutics are prescribed drugs used in the treatment of depression and other mental disorders. Many antidepressants carry the risk of developing addiction, though they do have many benefits for patients with depression or anxiety who do not commit abuse or other illegal behavior. Unfortunately, because antidepressants are such a common medication, doctors and patients frequently don't recognize the potential for addiction. There have been very few studies on the addictive qualities of antidepressants.
Although it is relatively uncommon, some physicians will prescribe antidepressants even when the doctor is not sure that the patient is taking an antidepressant or not under any duress or taking too seriously the adverse side effects of the drugs. Depression Therapeutics can have both short-term and long-term effects. If you take antidepressants for an extended period of time, or if you take them for several weeks, you may develop symptoms of psychological withdrawal if you stop taking the medications. If you have developed symptoms of psychological withdrawal, talk to your doctor about the possibility of reducing your dose or eliminating the antidepressant.
The primary antidepressants are tricyclic and related antidepressants, selective serotonin re-uptake inhibitors (SSRIs), the selective serotonin and norepinephrine re-uptake inhibitors (SNRIs) and the monoamine oxidase inhibitors (MAOIs). The U.S. Food and Drug Administration (FDA) has approved these tricyclic antidepressants to treat depression: Amitriptyline, Amoxapine, Desipramine (Norpramin), Doxepin, Imipramine (Tofranil), Nortriptyline (Pamelor), Protriptyline, and Trimipramine. SSRIs are the most commonly prescribed depression therapeutics. SSRIs inhibit the reuptake of serotonin, thereby increasing serotonin activity. Citalopram (Cipramil), dapoxetine (Priligy), escitalopram (Cipralex), fluoxetine (Prozac or Oxactin), and fluvoxamine (Faverin) are some few types of SSRIs. Isocarboxazid (Marplan), Phenelzine (Nardil), Selegiline (Emsam), and Tranylcypromine (Parnate) are approved MAOIs to treat depression. Common side effects of depression therapeutics include, headache, nausea, dry mouth, insomnia, dizziness, and diarrhea or constipation.

Comments
Post a Comment